10 completed. 10 Phase 1, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 10 | Completed 10 |
| Phase 2 | 4 | Completed 4 |
Follow Hematological Malignancy: new trials by email Literature Review of Hematological Malignancy trials Research Report on Hematological Malignancy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Compare Forms of Nemtabrutinib (MK-1026) in Healthy Adult Participants (MK-1026-007) Nemtabrutinib - Hematological Malignancy | Phase 1 | Completed | Merck Sharp & Dohme LLC | 40 | 2023-08-28 | 2024-09-19 |
| Study Evaluating Food Effect and QTc in Patients With Advanced Malignancies Pelabresib - Advanced Malignancies, Solid Tumor | Phase 1 | Completed | Constellation Pharmaceuticals | 35 | 2021-07-20 | 2025-07-28 |
| VPA Expanded UCB Transplantation for Treatment of Patients With Hematological Malignancies Cord blood stem cells, Valproic Acid, Fludarabine - Hematological Malignancy, Acute Leukemia in Remission | Phase 1 | Completed | Alla Keyzner | 7 | 2019-02-21 | 2021-05-24 |
| A Study of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients isavuconazonium sulfate - intravenous, isavuconazonium sulfate - oral - Hematological Malignancy | Phase 1 | Completed | Astellas Pharma Global Development, Inc. | 49 | 2017-10-02 | 2024-11-19 |
| Phase I of Infusion of Selected Donor NK Cells After Allogeneic Stem Cell Transplantation NK Cell infusion - Hematological Malignancy | Phase 1 | Completed | Institut Paoli-Calmettes | 17 | 2013-04-01 | 2026-04-21 |
| Post-Transplant Bortezomib and High Dose Cyclophosphamide as Graft-Versus-Host Disease (GVHD) Prophylaxis Cohort 1-Bortezomib (Velcade ®), Cohort 2-Bortezomib (Velcade ®), Cohort 3-Bortezomib (Velcade ®) - Hematological Malignancy | Phase 1 / Phase 2 | Completed | Corewell Health West | 28 | 2012-04-01 | 2023-06-02 |
| A Phase I/II Study of Mis-Matched Immune Cells (AlloStim) in Patients With Advanced Hematological Malignancy AlloStim - Hematological Malignancy, Leukemia | Phase 1 / Phase 2 | Completed | Mirror Biologics, Inc. | 6 | 2010-12-01 | 2020-01-22 |
| A Study of Belinostat in Combination With Warfarin in Patients With Solid Tumors or Hematological Malignancies Belinostat, Warfarin - Solid Tumor, Hematological Malignancy | Phase 1 | Completed | Spectrum Pharmaceuticals, Inc | 27 | 2010-12-01 | 2015-09-23 |
| Phase 1/2 Dose Escalation and Efficacy Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies Isatuximab SAR650984, Dexamethasone - Hematological Malignancy | Phase 1 / Phase 2 | Completed | Sanofi | 351 | 2010-05-11 | 2024-11-01 |
| Suicide Gene Therapy for Donor Lymphocytes Infusion After Allogeneic Hematopoietic Stem Cell Transplantation donor lymphocyte infusion - Hematological Malignancy | Phase 1 / Phase 2 | Completed | Assistance Publique - Hôpitaux de Paris | 11 | 2010-02-01 | 2013-01-14 |
Hematologic Neoplasms (10) · Hodgkin Disease (2) · Leukemia (2) · Lymphoma (2) · Lymphoma, Non-Hodgkin (2) · Invasive Fungal Infections (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Multiple Myeloma (1) · Myelodysplastic Syndromes (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1) · Recurrence (1)
Hematologic Diseases (10) · Hemic and Lymphatic Diseases (10) · Neoplasms (10) · Neoplasms by Site (10) · Bone Marrow Diseases (2) · Disease Attributes (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Lymphatic Diseases (2) · Lymphoproliferative Disorders (2) · Neoplasms by Histologic Type (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Bacterial Infections and Mycoses (1) · Blood Protein Disorders (1)
Cyclophosphamide (2) · ARQ531 (1) · Bortezomib (1) · Dexamethasone (1) · Thiotepa (1) · Valproic Acid (1) · Warfarin (1) · belinostat (1) · fludarabine (1) · isatuximab (1) · isavuconazole (1)
Alla Keyzner (1) · Assistance Publique - Hôpitaux de Paris (1) · Astellas Pharma Global Development, Inc. (1) · Constellation Pharmaceuticals (1) · Corewell Health West (1) · Institut Paoli-Calmettes (1) · Merck Sharp & Dohme LLC (1) · Mirror Biologics, Inc. (1) · Sanofi (1) · Spectrum Pharmaceuticals, Inc (1)
United States (7) · France (3) · Israel (2) · Spain (2) · Argentina (1) · Belgium (1) · Brazil (1) · Chile (1) · Finland (1) · Georgia (1) · Greece (1) · Italy (1) · Mexico (1) · Peru (1) · Russia (1)
A. Samer Al-Homsi, MD (1) · Alla Keyzner, MD (1) · Dr. Michael Har-Noy (1) · Sunil Sharma, MD, FACP (1)
PMID 32409691, PMID 32718876, PMID 33080623, PMID 34031051, PMID 34071607